(2R,3S,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-3-ol

Catalog No. :
ACTSVC785
CAS No. :
925915-30-6
Molecular Formula :
C16H26ClN5O3Si
Molecular Weight :
399.95

IUPAC Name:(2R,3S,5R)-5-(2-amino-6-chloro-9H-purin-9-yl)-2-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-3-ol

(2R,3S,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-3-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$438.00Login to see priceInquiryInquiry
250mg95%$1052.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S,5R)-5-(2-Amino-6-chloro-9H-purin-9-yl)-2-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-3-ol
IUPAC Name(2R,3S,5R)-5-(2-amino-6-chloro-9H-purin-9-yl)-2-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-3-ol
Molecular FormulaC16H26ClN5O3Si
Molecular Weight399.95
SMILESCC(C)([Si](C)(OC[C@@H]1[C@@H](O)C[C@H](N2C=NC3=C2N=C(N)N=C3Cl)O1)C)C
InChI KeyVKMQNHZFYYKQHR-HBNTYKKESA-N
Synonym6-?Chloro-?9-?[2-?deoxy-?5-?O-?[(1,?1-?dimethylethyl)?dimethylsilyl]?-?Beta-?D-?erythro-?pentofuranosyl]?-9H-?purin-?2-?amine;9H-Purin-2-amine, 6-chloro-9-[2-deoxy-5-O-[(1,1-dimethylethyl)dimethylsilyl]-β-D-erythro-pentofuranosyl]-
CAS No.925915-30-6

Synthetic Route by SureRoute

1. ACTSVC785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTSVC785 route product structure diagram
    ACTSVC785925915-30-6
Inquiry

2. ACTSVC785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACTSVC785 route product structure diagram
    ACTSVC785925915-30-6
Inquiry

Comments (0)